The Next 10 Years (2024) To Hold The Baton Of Growth Of Antibody Library Technology Market Based On Technological Advancements At A CAGR Of 4.4%

The Antibody Library Technology Market is bound to reach US$ 100 Million at a CAGR of 4.4% between 2024. The modern-day situation says that the healthcare sector is witnessing an optimization and reposition of the business models to obtain enhanced patient outcomes. With real-time analytics known to improve patient care and the fact that consumers are shifting towards the preventive model of care, the healthcare vertical is likely to witness greater strides in the forecast period.

Demand for antibody library technologies is expected to surge, as the arrival of advanced antibodies and their display technologies continue to reduce complexities of life science and biotechnology research.

Persistence Market Research (PMR), in its latest report, projects that the global antibody library technologies market revenue will increase at a CAGR of 4.4% between 2016 and 2024. Some of the latest antibody library design and selection methods enable easy identification of any MAB with any specificity, which is why pharmaceutical companies are increasingly making use of such technologies in their facilities.

Strategizing The Moves For The Next Decade? See Through Sample Of Antibody Library Technology Market Report!

Company Profiles

  • MorphoSys AG
  • Dyax Corp.
  • Abzena Plc.
  • XOMA Corporation
  • AvantGen Inc.
  • Creative-biolabs
  • AbCheck s.r.o.
  • Philogen S.p.A.
  • Adimab LLC
  • Invenra Inc.
  • AnaptysBio, Inc.
  • Abwiz Bio Inc.
  • Abgent Inc. (WuXi AppTec company)
  • Vaccinex Inc.
  • AxioMx Inc.
  • Others

“Owing to the limitation and shortcomings of the conventional molecular display technologies, biomedical research organizations are now shifting towards new age display less’ technologies, capable of isolating antibodies up to subnanomolar affinities.” – Analyst, Persistence Market Research

Global Antibody Library Technologies: Key Market Trends

  • As the market becomes more competitive, players aim to offer additional services complementary to antibody libraries.
  • Consolidation between technology developers and drug development organizations in order to increase the consumer base has been identified as a prominent trend in the global market for antibody library technologies.
  • Widespread adoption of cell-free display platform will persist throughout the forecast period, owing to the compact nature of such contemporary display platforms. For instance, the popularity of cell-free ribosome display technology has grown significantly amongst end-users in recent years.

Starting With The New Decade On A Diligent Note In The Antibody Library Technology Market?

Highlights of the Report Include

Phage display to remain as the predominant antibody library technology in 2017 and beyond. Moreover, constant technological advancement is expected to support its widespread adoption in the medium term. Phage display was the first in vitro technology developed for antibody selection and is extensively used by scientists all over the world. In 2016, sales revenue of phage display technology reached US$ 68.0 Million and is likely increase at 5% CAGR over 2024.

How About Obtaining Insights About The Region To Enter Concerning The Antibody Library Technology Market? Press The “Purchase Now” Button To Have Our Antibody Library Technology Market Report!

Based on application, antibody library technologies are primarily used in drug discovery programs. Nearly US$ 81.3 Million worth antibody library technologies were purchased for drug development purposes in 2016. Meanwhile, biopharmaceutical companies remain the major end users of such technologies and are expected to create an incremental opportunity of US$ 44.Mn between 2016 and 2026 for the market.

Amongst all the key regions, the antibody library technologies market in North America accounted for a massive revenue share of 57.5% in 2015.

This is primarily due to the favorable government initiatives for development of cost-effective monoclonal antibodies in the US, which is driving the demand for antibody library technologies in the region. North America will continue to be most lucrative market over the forecast period followed by Europe and APAC.

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007, United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –

Back to top button